Cell Culture Company’s hollow fiber bioreactor technology is most appropriate for challenging, small to mid-scale protein production. This includes pre-clinical, toxicology, ex vivo, and clinical trial protein production. This technology is also very appropriate for difficult-to-express proteins and for autologous applications due to the small bioreactor footprint and fast turnaround.